Jiangsu Hanbon Science and Technology Co., Ltd. (SHA:688755)
24.30
-0.70 (-2.80%)
At close: Nov 13, 2026
SHA:688755 Revenue
Jiangsu Hanbon Science and Technology had revenue of 202.02M CNY in the quarter ending September 30, 2026, with 28.67% growth. This brings the company's total for the last twelve months to 849.02M, up 19.05% year-over-year. In the year 2025, Jiangsu Hanbon Science and Technology had annual revenue of 735.13M with 6.40% growth. That makes Jiangsu Hanbon Science and Technology the 20,898th largest company in the world by revenue and 3,839th in China.
Revenue (ttm)
849.02M
Revenue Growth
+19.05%
P/S Ratio
3.27
Revenue / Employee
1.17M
Employees
728
Market Cap
2.78B
Revenue by Geography
- China 640.70M 87.2%
- Overseas 94.24M 12.8%
Fiscal year ended Dec 31, 2025 See the full SHA:688755 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 735.13M | 44.25M | 6.40% |
| Dec 31, 2024 | 690.88M | 71.87M | 11.61% |
| Dec 31, 2023 | 619.01M | 137.22M | 28.48% |
| Dec 31, 2022 | 481.79M | 161.28M | 50.32% |
| Dec 31, 2021 | 320.51M | 18.23M | 6.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.72B |
| Guangdong Transtek Medical Electronics | 1.05B |
| Chison Medical Technologies | 443.67M |
| Jiangsu Canopus Wisdom Medical Technology | 433.55M |
| Tellgen | 393.84M |
| Nanjing Medlander Medical Technology | 382.77M |
| Shanghai General Healthy Information and Technology | 350.19M |
| CareRay Digital Medical Technology | 322.80M |